{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:49:27Z","timestamp":1790830167973,"version":"4.1.0"},"reference-count":62,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Brain tumors account for 1% of all cancers diagnosed de novo. Due to the specificity of the anatomical area in which they grow, they can cause significant neurological disorders and lead to poor functional status and disability. Regardless of the results of biochemical markers of intracranial neoplasms, they are currently of no diagnostic significance. The aim of the study was to use LC-ESI-MS\/MS in conjunction with multivariate statistical analyses to examine changes in amino acid metabolic profiles between patients with glioblastoma, meningioma, and a group of patients treated for osteoarthritis of the spine as a control group. Comparative analysis of amino acids between patients with glioblastoma, meningioma, and the control group allowed for the identification of statistically significant differences in the amino acid profile, including both exogenous and endogenous amino acids. The amino acids that showed statistically significant differences (lysine, histidine, \u03b1-aminoadipic acid, phenylalanine) were evaluated for diagnostic usefulness based on the ROC curve. The best results were obtained for phenylalanine. Classification trees were used to build a model allowing for the correct classification of patients into the study group (patients with glioblastoma multiforme) and the control group, in which cysteine turned out to be the most important amino acid in the decision-making algorithm. Our results indicate amino acids that may prove valuable, used alone or in combination, toward improving the diagnosis of patients with glioma and meningioma. To better assess the potential utility of these markers, their performance requires further validation in a larger cohort of samples.<\/jats:p>","DOI":"10.3390\/molecules28237699","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T04:21:27Z","timestamp":1700626887000},"page":"7699","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative Analysis of Amino Acid Profiles in Patients with Glioblastoma and Meningioma Using Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS\/MS)"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0684-117X","authenticated-orcid":false,"given":"Piotr","family":"Ko\u015bli\u0144ski","sequence":"first","affiliation":[{"name":"Department of Toxicology and Bromatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4573-3614","authenticated-orcid":false,"given":"Robert","family":"Pluskota","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Bromatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-1443","authenticated-orcid":false,"given":"Marcin","family":"Koba","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Bromatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zygmunt","family":"Siedlecki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neurotraumatology and Pediatric Neurosurgery, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"\u015aniegocki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neurotraumatology and Pediatric Neurosurgery, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ncl.2007.07.002","article-title":"Epidemiology of Brain Tumors","volume":"25","author":"Fisher","year":"2007","journal-title":"Neurol. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11060-016-2318-3","article-title":"Epidemiology for Primary Brain Tumors: A Nationwide Population-Based Study","volume":"131","author":"Darlix","year":"2017","journal-title":"J. Neurooncol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Polly, F.P., Shil, S.K., Hossain, M.A., Ayman, A., and Jang, Y.M. (2018, January 10\u201312). Detection and Classification of HGG and LGG Brain Tumor Using Machine Learning. Proceedings of the 2018 International Conference on Information Networking (ICOIN), Chiang Mai, Thailand.","DOI":"10.1109\/ICOIN.2018.8343231"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","article-title":"Epidemiology and Etiology of Gliomas","volume":"109","author":"Ohgaki","year":"2005","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"III1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro-oncology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1079597","DOI":"10.3389\/fonc.2023.1079597","article-title":"Epidemiology and Risk Stratification of Low-Grade Gliomas in the United States, 2004-2019: A Competing-Risk Regression Model for Survival Analysis","volume":"13","author":"Cao","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_7","first-page":"99","article-title":"Epidemiology, Diagnosis, and Optimal Management of Glioma in Adolescents and Young Adults","volume":"8","author":"Diwanji","year":"2017","journal-title":"Adolesc. Health Med. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/cncr.21733","article-title":"Survival Rates and Patterns of Care for Patients Diagnosed with Supratentorial Low-Grade Gliomas: Data from the SEER Program, 1973\u20132001","volume":"106","author":"Claus","year":"2006","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH Mutation in Glioma: Molecular Mechanisms and Potential Therapeutic Targets","volume":"122","author":"Han","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and Etiology of Meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J. Neurooncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.wneu.2016.09.094","article-title":"Radiation-Induced Meningiomas: An Exhaustive Review of the Literature","volume":"97","author":"Yamanaka","year":"2017","journal-title":"World Neurosurg."},{"key":"ref_12","first-page":"212","article-title":"Immunohistochemical Detection of Female Sex Hormone Receptors in Meningiomas: Correlation with Clinical and Histological Features Clinical Study","volume":"33","author":"Franz","year":"1992","journal-title":"Neurosurgery"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-802997-8.00002-5","article-title":"Presenting Signs and Symptoms in Brain Tumors","volume":"Volume 134","author":"Alentorn","year":"2016","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0736-4679(93)90042-6","article-title":"Signs and Symptoms of Patients with Brain Tumors Presenting to the Emergency Department","volume":"11","author":"Snyder","year":"1993","journal-title":"J. Emerg. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrc2818","article-title":"Targeting Brain Cancer: Advances in the Molecular Pathology of Malignant Glioma and Medulloblastoma","volume":"10","author":"Huse","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.7314\/APJCP.2013.14.9.5225","article-title":"Elevated Serum IL-17A but Not IL-6 in Glioma versus Meningioma and Schwannoma","volume":"14","author":"Doroudchi","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fonc.2020.00478","article-title":"Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40","volume":"10","author":"Holst","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12953-014-0047-0","article-title":"Potential Serum Biomarkers for Glioblastoma Diagnostic Assessed by Proteomic Approaches","volume":"12","author":"Popescu","year":"2014","journal-title":"Proteome Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gautam, P., Nair, S.C., Gupta, M.K., Sharma, R., Polisetty, R.V., Uppin, M.S., Sundaram, C., Puligopu, A.K., Ankathi, P., and Purohit, A.K. (2012). Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by ITRAQ-Based Quantitative Proteomic Analysis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046153"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41598-019-39067-8","article-title":"Serum Biomarkers Identification by ITRAQ and Verification by MRM: S100A8\/S100A9 Levels Predict Tumor-Stroma Involvement and Prognosis in Glioblastoma","volume":"9","author":"Arora","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/neuonc\/now034","article-title":"Elevated Levels of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients with Glioblastoma Highly Express S100A8\/9 and Arginase and Suppress T Cell Function","volume":"18","author":"Gielen","year":"2016","journal-title":"Neuro-oncology"},{"key":"ref_22","first-page":"678","article-title":"Neurospecificity Proteins in the Serum of Patients with Brain Tumors","volume":"150","author":"Lyubimova","year":"2010","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/pmic.201200002","article-title":"Investigation of Serum Proteome Alterations in Human Glioblastoma Multiforme","volume":"12","author":"Gollapalli","year":"2012","journal-title":"Proteomics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fphar.2018.00886","article-title":"Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jprot.2015.07.026","article-title":"Definition of a Serum Marker Panel for Glioblastoma Discrimination and Identification of Interleukin 1\u03b2 in the Microglial Secretome as a Novel Mediator of Endothelial Cell Survival Induced by C-Reactive Protein","volume":"128","author":"Nijaguna","year":"2015","journal-title":"J. Proteom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/2017.3.JNS161648","article-title":"Diagnostic Value of Preoperative Inflammatory Markers in Patients with Glioma: A Multicenter Cohort Study","volume":"129","author":"Zheng","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/prca.200900173","article-title":"Plasma Proteome Profiling Reveals Biomarker Patterns Associated with Prognosis and Therapy Selection in Glioblastoma Multiforme Patients","volume":"4","author":"Carlsson","year":"2010","journal-title":"Proteom. Clin. Appl."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Linhares, P., Carvalho, B., Vaz, R., and Costa, B.M. (2020). Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165809"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"665235","DOI":"10.3389\/fonc.2021.665235","article-title":"Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review","volume":"11","author":"Ali","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"\u015aledzi\u0144ska, P., Bebyn, M.G., Furtak, J., Kowalewski, J., and Lewandowska, M.A. (2021). Prognostic and Predictive Biomarkers in Gliomas. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910373"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/nbm.2794","article-title":"Metabolism of [U-13C]Glucose in Human Brain Tumors in Vivo","volume":"25","author":"Maher","year":"2012","journal-title":"NMR Biomed."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","article-title":"Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases","volume":"159","author":"Mashimo","year":"2014","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/iub.2149","article-title":"Metabolomic Profiling of Blood Plasma in Patients with Primary Brain Tumours: Basal Plasma Metabolites Correlated with Tumour Grade and Plasma Biomarker Analysis Predicts Feasibility of the Successful Statistical Discrimination from Healthy Subjects\u2014A Preliminary Study","volume":"71","author":"Galanda","year":"2019","journal-title":"IUBMB Life"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/mc.22694","article-title":"Metabolomic Signature of Brain Cancer","volume":"56","author":"Pandey","year":"2017","journal-title":"Mol. Carcinog."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Masalha, W., Daka, K., Woerner, J., Pompe, N., Weber, S., Delev, D., Kr\u00fcger, M.T., Schnell, O., Beck, J., and Heiland, D.H. (2021). Metabolic Alterations in Meningioma Reflect the Clinical Course. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07887-5"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ferrasi, A.C., Puttini, R., Galvani, A.F., Hamamoto Filho, P.T., Delafiori, J., Argente, V.D., de Oliveira, A.N., Dias-Audibert, F.L., Catharino, R.R., and Silva, O.C. (2023). Metabolomics Approach Reveals Important Glioblastoma Plasma Biomarkers for Tumor Biology. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108813"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-12-1572-T","article-title":"The Metabolomic Signature of Malignant Glioma Reflects Accelerated Anabolic Metabolism","volume":"72","author":"Chinnaiyan","year":"2012","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"70366","DOI":"10.18632\/oncotarget.19705","article-title":"A Prospective Study of Serum Metabolites and Glioma Risk","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"M111.014688","DOI":"10.1074\/mcp.M111.014688","article-title":"Metabolomics of Human Cerebrospinal Fluid Identifies Signatures of Malignant Glioma","volume":"11","author":"Locasale","year":"2012","journal-title":"Mol. Cell. Proteom."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11060-013-1090-x","article-title":"GC\/MS-Based Metabolomic Analysis of Cerebrospinal Fluid (CSF) from Glioma Patients","volume":"113","author":"Nakamizo","year":"2013","journal-title":"J. Neurooncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kurokawa, G.A., Hamamoto Filho, P.T., Delafiori, J., Galvani, A.F., de Oliveira, A.N., Dias-Audibert, F.L., Catharino, R.R., Pardini, M.I.M.C., Zanini, M.A., and Lima, E.d.O. (2023). Differential Plasma Metabolites between High- and Low-Grade Meningioma Cases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010394"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Metabolomics: The Apogee of the Omics Trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1742-4658.2007.05676.x","article-title":"A Metabolomics Perspective of Human Brain Tumours","volume":"274","author":"Griffin","year":"2007","journal-title":"FEBS J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/s41467-020-16810-8","article-title":"Using Arterial\u2013Venous Analysis to Characterize Cancer Metabolic Consumption in Patients","volume":"11","author":"Xiong","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Wei, Z., Liu, X., Cheng, C., Yu, W., and Yi, P. (2021). Metabolism of Amino Acids in Cancer. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.603837"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chen, S., Jiang, J., Shen, A., Miao, Y., Cao, Y., Zhang, Y., Cong, P., and Gao, P. (2022). Rewired Metabolism of Amino Acids and Its Roles in Glioma Pathology. Metabolites, 12.","DOI":"10.3390\/metabo12100918"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bernhard, C., Reita, D., Martin, S., Entz-Werle, N., and Dontenwill, M. (2023). Glioblastoma Metabolism: Insights and Therapeutic Strategies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119137"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41392-023-01380-0","article-title":"To Metabolomics and beyond: A Technological Portfolio to Investigate Cancer Metabolism","volume":"8","author":"Danzi","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.4537","article-title":"Purine Synthesis Promotes Maintenance of Brain Tumor Initiating Cells in Glioma","volume":"20","author":"Wang","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1158\/1078-0432.CCR-15-2308","article-title":"Methionine and Kynurenine Activate Oncogenic Kinases in Glioblastoma, and Methionine Deprivation Compromises Proliferation","volume":"22","author":"Palanichamy","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/0008-5472.CAN-13-1423","article-title":"Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth","volume":"74","author":"Prabhu","year":"2014","journal-title":"Cancer Res."},{"key":"ref_52","first-page":"283","article-title":"Specific Alterations in the Serum Amino Acid Profile of Patients with Lung Cancer and Head and Neck Cancer","volume":"29","author":"Dols","year":"2006","journal-title":"Oncologica"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s12094-020-02494-5","article-title":"The Free Amino Acid Profiles and Metabolic Biomarkers of Predicting the Chemotherapeutic Response in Advanced Sarcoma Patients","volume":"22","author":"Jia","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2291759","DOI":"10.1155\/2020\/2291759","article-title":"Prognostic Role of Serum Amino Acids in Head and Neck Cancer","volume":"2020","author":"Cadoni","year":"2020","journal-title":"Dis. Markers"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-023-04329-z","article-title":"Tissue and Plasma Free Amino Acid Detection by LC-MS\/MS Method in High Grade Glioma Patients","volume":"163","author":"Toklu","year":"2023","journal-title":"J. Neurooncol"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13014-016-0626-6","article-title":"Characterization of the Serum Metabolome Following Radiation Treatment in Patients with High-Grade Gliomas","volume":"11","author":"Wibom","year":"2016","journal-title":"Radiat. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1172\/JCI64801","article-title":"2-Aminoadipic Acid Is a Biomarker for Diabetes Risk","volume":"123","author":"Wang","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","article-title":"New Aspects of Amino Acid Metabolism in Cancer","volume":"122","author":"Vettore","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/1097-0142(19841101)54:9<1875::AID-CNCR2820540918>3.0.CO;2-O","article-title":"Serum Amino Acid Levels in Patients With Hepatocellular Carcinoma","volume":"54","author":"Watanabe","year":"1984","journal-title":"Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","article-title":"Soluble Receptors for Tumour Necrosis Factor in Clinical Laboratory Diagnosis","volume":"54","author":"Tilz","year":"1995","journal-title":"Eur. J. Haematol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2008.07.002","article-title":"Serum Phenylalanine Concentrations in Patients with Ovarian Carcinoma Correlate with Concentrations of Immune Activation Markers and of Isoprostane-8","volume":"272","author":"Neurauter","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00726-007-0625-x","article-title":"Serum Phenylalanine in Patients Post Trauma and with Sepsis Correlate to Neopterin Concentrations","volume":"35","author":"Ploder","year":"2008","journal-title":"Amino Acids"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/23\/7699\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:26:46Z","timestamp":1760131606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/23\/7699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":62,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["molecules28237699"],"URL":"https:\/\/doi.org\/10.3390\/molecules28237699","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}